219 related articles for article (PubMed ID: 20534139)
1. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era.
Coquet I; Pavie J; Palmer P; Barbier F; Legriel S; Mayaux J; Molina JM; Schlemmer B; Azoulay E
Crit Care; 2010; 14(3):R107. PubMed ID: 20534139
[TBL] [Abstract][Full Text] [Related]
2. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit.
Croda J; Croda MG; Neves A; De Sousa dos Santos S
Crit Care Med; 2009 May; 37(5):1605-11. PubMed ID: 19325488
[TBL] [Abstract][Full Text] [Related]
3. Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors.
Chiang HH; Hung CC; Lee CM; Chen HY; Chen MY; Sheng WH; Hsieh SM; Sun HY; Ho CC; Yu CJ
Crit Care; 2011 Aug; 15(4):R202. PubMed ID: 21871086
[TBL] [Abstract][Full Text] [Related]
4. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.
Casalino E; Wolff M; Ravaud P; Choquet C; Bruneel F; Regnier B
AIDS; 2004 Jul; 18(10):1429-33. PubMed ID: 15199319
[TBL] [Abstract][Full Text] [Related]
5. Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.
Greenberg JA; Lennox JL; Martin GS
J Crit Care; 2012 Feb; 27(1):51-7. PubMed ID: 22033058
[TBL] [Abstract][Full Text] [Related]
6. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients.
Japiassú AM; Amâncio RT; Mesquita EC; Medeiros DM; Bernal HB; Nunes EP; Luz PM; Grinsztejn B; Bozza FA
Crit Care; 2010; 14(4):R152. PubMed ID: 20698966
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in critically Ill HIV-infected patients between 1997 and 2020: analysis of the OUTCOMEREA multicenter cohort.
Gaillet A; Azoulay E; de Montmollin E; Garrouste-Orgeas M; Cohen Y; Dupuis C; Schwebel C; Reignier J; Siami S; Argaud L; Adrie C; Mourvillier B; Ruckly S; Forel JM; Timsit JF
Crit Care; 2023 Mar; 27(1):108. PubMed ID: 36915207
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and outcome of HIV-infected patients admitted to the ICU in the current highly active antiretroviral therapy era.
Vidal-Cortés P; Álvarez-Rocha LA; Fernández-Ugidos P; Pérez-Veloso MA; Suárez-Paul IM; Virgós-Pedreira A; Pértega-Díaz S; Castro-Iglesias ÁC
Med Intensiva (Engl Ed); 2020; 44(5):283-293. PubMed ID: 30971339
[TBL] [Abstract][Full Text] [Related]
9. Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy.
Powell K; Davis JL; Morris AM; Chi A; Bensley MR; Huang L
Chest; 2009 Jan; 135(1):11-17. PubMed ID: 18719058
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and Outcomes of HIV-Infected Patients With Severe Sepsis: Continued Risk in the Post-Highly Active Antiretroviral Therapy Era.
Cribbs SK; Tse C; Andrews J; Shenvi N; Martin GS
Crit Care Med; 2015 Aug; 43(8):1638-45. PubMed ID: 25853590
[TBL] [Abstract][Full Text] [Related]
11. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy.
Adlakha A; Pavlou M; Walker DA; Copas AJ; Dufty N; Batson S; Edwards SG; Singer M; Miller RF
Int J STD AIDS; 2011 Sep; 22(9):498-504. PubMed ID: 21890545
[TBL] [Abstract][Full Text] [Related]
12. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Khouli H; Afrasiabi A; Shibli M; Hajal R; Barrett CR; Homel P
J Intensive Care Med; 2005; 20(6):327-33. PubMed ID: 16280405
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era.
Vincent B; Timsit JF; Auburtin M; Schortgen F; Bouadma L; Wolff M; Regnier B
Intensive Care Med; 2004 May; 30(5):859-66. PubMed ID: 14767592
[TBL] [Abstract][Full Text] [Related]
14. Early antiretroviral therapy for HIV-infected patients admitted to an intensive care unit (EARTH-ICU): A randomized clinical trial.
Boniatti MM; Pellegrini JAS; Marques LS; John JF; Marin LG; Maito LRDM; Lisboa TC; Damiani LP; Falci DR
PLoS One; 2020; 15(9):e0239452. PubMed ID: 32956419
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of risk factors of prolonged intensive care unit stay of critically ill obstetric patients: a 5-year retrospective review in 3 hospitals in Beijing].
Lin Y; Zhu X; Liu F; Zhao YY; Du J; Yao GQ; Li WX; Jia XJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):449-53. PubMed ID: 21878165
[TBL] [Abstract][Full Text] [Related]
16. Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era.
Akgün KM; Tate JP; Pisani M; Fried T; Butt AA; Gibert CL; Huang L; Rodriguez-Barradas MC; Rimland D; Justice AC; Crothers K
Crit Care Med; 2013 Jun; 41(6):1458-67. PubMed ID: 23507717
[TBL] [Abstract][Full Text] [Related]
17. What determines do-not-resuscitate status in critically ill HIV-infected patients admitted to ICU?
Gregory AB; Turvey SL; Bagshaw SM; Sligl WI
J Crit Care; 2019 Oct; 53():207-211. PubMed ID: 31271956
[TBL] [Abstract][Full Text] [Related]
18. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy.
Dickson SJ; Batson S; Copas AJ; Edwards SG; Singer M; Miller RF
Thorax; 2007 Nov; 62(11):964-8. PubMed ID: 17517829
[TBL] [Abstract][Full Text] [Related]
19. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia.
Morris A; Wachter RM; Luce J; Turner J; Huang L
AIDS; 2003 Jan; 17(1):73-80. PubMed ID: 12478071
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in critically ill cancer patients admitted to the intensive care unit.
Aygencel G; Turkoglu M; Turkoz Sucak G; Benekli M
J Crit Care; 2014 Aug; 29(4):618-26. PubMed ID: 24612762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
